Skip to content

Study on the analgesic and gastrointestinal function protection effects of oxycodone on patients undergoing long-term laparoscopic colorectal surgery

Study on the analgesic and gastrointestinal function protection effects of oxycodone on patients undergoing long-term laparoscopic colorectal surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096929
Enrollment
Unknown
Registered
2025-02-10
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Oxycodone group:Oxycodone group (Q group): intravenous midazolam 0.03 mg/kg, oxycodone 0.3 mg/kg, propofol 1.5 mg/kg and cisatracurium 0.2 mg/kg were induced by anesthesia. Flurbiprofen cilofen 50 mg
Fentanyl group:Fentanyl group (group C): intravenous midazolam 0.03 mg/kg, fentanyl 2 µg/kg, propofol 1.5 mg/kg and cis-atracurium 0.2 mg/kg were induced, and flurbiprofen axil 50 mg and fentanyl inje

Sponsors

Tianjin People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Inpatients who choose ASA grade I.~III. in our hospital and plan to undergo elective laparoscopic surgery; The operation time >= 3 hours; (2) Age >= 18 years old, gender is not limited; (3) The academic requirements need to be at the junior high school level or above (the duration of education > 6 years), and be able to understand the content of the NRS rating scale within an interpretable range.

Exclusion criteria

Exclusion criteria: (1) Gastrointestinal ischemic diseases (esophageal cancer, Crohn's disease, ulcerative intestinal diseases, necrotizing enteritis and stress ulcers, etc.); (2) Patients who continue to use psychotropic drugs; (3) Patients with severe heart, lung, liver, and kidney diseases; (4) Patients with hypertension and poor control, tachycardia and poor control; (5) Patients with severe visual and hearing impairments; (6) Patients who are unable or unwilling to cooperate in completing neurological dysfunction testing; (7) Patients with contraindications to the use of oxycodone.

Design outcomes

Primary

MeasureTime frame
NRS pain scores at 2, 4, 8, 24, 48, 72 hours postoperatively;Use of salvage analgesics within 72 hours after surgery;Time to first postoperative gas and bowel movement;Postoperative gastrointestinal function;Serum I-FABP concentration;Gastrin (GAS) levels;

Secondary

MeasureTime frame
General preoperative;Intraoperative propofol dosage;Remifentanil dosage;

Countries

China

Contacts

Public ContactShuhua Xie

Tianjin People's Hospital

xieshuhua001@123.com+86 150 2268 9349

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026